Sign In
Buy DHR
$178.08
+1.97 (+1.12%)
At Close: Jun 03, 2026
Seeking Clues to Danaher (DHR) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics
10:20am, Thursday, 25'th Jan 2024
Beyond analysts' top -and-bottom-line estimates for Danaher (DHR), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter
Danaher (DHR) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
11:07am, Tuesday, 23'rd Jan 2024
Danaher (DHR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Danaher (DHR) is Poised to Beat Earnings Estimates Again
01:11pm, Wednesday, 17'th Jan 2024
Danaher (DHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Charts turn bullish on health-care stocks as sector takes early lead in 2024
11:29am, Tuesday, 16'th Jan 2024
Chart-watchers are growing increasingly bullish on health-care stocks now that they have become the best-performing sector of the S&P 500 so far in 2024, according to Dow Jones Market Data. Analysts h
Danaher (DHR) Stock Declines While Market Improves: Some Information for Investors
07:34pm, Wednesday, 10'th Jan 2024
Danaher (DHR) closed the most recent trading day at $229.64, moving -0.53% from the previous trading session.
Will Danaher stock hit new highs in 2024?
07:06am, Wednesday, 10'th Jan 2024
Danaher Corporation NYSE: DHR shares went into a tailspin when the Abcam deal came into question, but the dip turned out to be a buying opportunity in this life-sciences company. The dip hit bottom so
Here's Why Danaher (DHR) Fell More Than Broader Market
07:32pm, Wednesday, 03'rd Jan 2024
The latest trading day saw Danaher (DHR) settling at $230.81, representing a -1.7% change from its previous close.
Danaher to Present at J.P. Morgan Healthcare Conference
05:00pm, Tuesday, 02'nd Jan 2024
WASHINGTON , Jan. 2, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the J.P.
Investor Michael Farr is back with his top 10 stocks he's buying for 2024, and the tilt is defensive
02:02pm, Thursday, 28'th Dec 2023
This year's list is a bit more defensive than in years past and has a focus on earnings growth.
Danaher: Continuously Compounding
09:49am, Thursday, 28'th Dec 2023
Danaher has undergone a radical transformation from a real estate trust to a leader in the life sciences industry through strategic acquisitions. The company's focus on continuous improvement and effi
My Top 2024 Stock Pick: Danaher
05:54pm, Wednesday, 27'th Dec 2023
Danaher is my low-risk SWAN stock pick for 2024, with a strong track record of growth and a focus on rational, data-driven decision-making at its core. The end market for Danaher's healthcare and biop
Top 3 Healthcare Stock Picks for the New Year
08:14pm, Monday, 25'th Dec 2023
After lagging most sectors in 2023, healthcare stocks could deliver substantial returns in 2024. The market has been overly pessimistic about the sector due to short-term challenges.
Danaher Schedules Fourth Quarter 2023 Earnings Conference Call
04:30pm, Thursday, 21'st Dec 2023
WASHINGTON , Dec. 21, 2023 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the fourth quarter 2023 on Tuesday, January 30, 20
Reasons to Retain Danaher (DHR) Stock in Your Portfolio Now
12:02pm, Tuesday, 19'th Dec 2023
Strength in the Life Sciences segment and accretive acquisition bode well for Danaher (DHR). The company's measures to reward its shareholders are encouraging.
Danaher (DHR) Stock Falls Amid Market Uptick: What Investors Need to Know
07:32pm, Monday, 18'th Dec 2023
Danaher (DHR) closed the most recent trading day at $226.45, moving -0.34% from the previous trading session.
